The data were presented at the Keystone Symposium Targeting Dry Age-related Macular Degeneration: Pathophysiology and ...

Robert Osher, MD, sat down with David Hutton of Ophthalmology Times to discuss the Lifetime Achievement award he received ...

The University of Arkansas for Medical Sciences (UAMS) has received a 5-year federal grant for nearly $2.2 million to study ...

The American Academy of Ophthalmology (AAO) is holding its annual meeting October 18 to 21 at McCormick Place in Chicago, ...

Corneal cross-linking (CXL) has transformed the disease course of patients with corneal ectasias since its introduction to ...

Researchers at the Karolinska Institute continue to investigate whether gene therapy can improve vision in people with ...

David A. Eichenbaum, MD, presented key data from two clinical trials focusing on therapies for age-related macular ...

The announcement marks the second FDA designation for ATSN-201, which previously received Rare Pediatric Disease designation.

The report urges the US Department of Health and Human Services, in collaboration with departments of education at the state ...

The acquisition strengthens the company’s rare disease segment, and adds 2 durable commercial assets, Iluvien and Yutiq with ...

According to the company, topline results will be presented at the 2024 American Academy of Ophthalmology Annual Meeting, ...

Durga Borkar, MD, sat down with Sydney Crago of Modern Retina to discuss one of her presentations on the first time phase 2 ...